Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.transproceed.2021.01.002 http://scihub22266oqcxt.onion/10.1016/j.transproceed.2021.01.002 33573820!7836220!33573820     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transplant+Proc 2021 ; 53 (4): 1187-1193 Nephropedia Template TP {{tp|p=33573820|t=2021. Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study |pdf=|usr=}}{{33573820}} gab.com Text Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study JO: Transplant Proc http://www.kidney.de/pget.php?&tw=1&pmid=33573820 #FOAvip BACKGROUND: Kidney transplant recipients (KTR) are considered high-risk for morbidity and mortality from coronavirus disease 2019 (COVID-19). However, some studies did not show worse outcomes compared to non-transplant patients and there is little data about immunosuppressant drug levels and secondary infections in KTR with COVID-19. Herein, we describe our single-center experience with COVID-19 in KTR. METHODS: We captured KTR diagnosed with COVID-19 between March 1, 2020 and May 18, 2020. After exclusion of KTR on hemodialysis and off immunosuppression, we compared the clinical course of COVID-19 between hospitalized KTR and non-transplant patients, matched by age and sex (controls). RESULTS: Eleven KTR were hospitalized and matched with 44 controls. One KTR and 4 controls died (case fatality rate: 9.1%). There were no significant differences in length of stay or clinical outcomes between KTR and controls. Tacrolimus or sirolimus levels were >10 ng/mL in 6 out of 9 KTR (67%). Bacterial infections were more frequent in KTR (36.3%), compared with controls (6.8%, P = .02). CONCLUSIONS: In our small case series, unlike earlier reports from the pandemic epicenters, the clinical outcomes of KTR with COVID-19 were comparable to those of non-transplant patients. Calcineurin or mammalian target of rapamycin inhibitor (mTOR) levels were high. Bacterial infections were more common in KTR, compared with controls. Twit Text FOAVip Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study ????Transplant Proc http://www.kidney.de/pget.php?&tw=1&pmid=33573820 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33573820 #FOAvip English Wikipedia <ref>{{Cite pmid|33573820}}</ref> Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Center Experience and Case-Control Study #MMPMID33573820 Hardesty A; Pandita A; Vieira K; Rogers R; Merhi B; Osband AJ; Aridi J; Shi Y; Bayliss G; Cosgrove C; Gohh R; Morrissey P; Beckwith CG; Farmakiotis D Transplant Proc 2021[May]; 53 (4): 1187-1193 PMID33573820show ga BACKGROUND: Kidney transplant recipients (KTR) are considered high-risk for morbidity and mortality from coronavirus disease 2019 (COVID-19). However, some studies did not show worse outcomes compared to non-transplant patients and there is little data about immunosuppressant drug levels and secondary infections in KTR with COVID-19. Herein, we describe our single-center experience with COVID-19 in KTR. METHODS: We captured KTR diagnosed with COVID-19 between March 1, 2020 and May 18, 2020. After exclusion of KTR on hemodialysis and off immunosuppression, we compared the clinical course of COVID-19 between hospitalized KTR and non-transplant patients, matched by age and sex (controls). RESULTS: Eleven KTR were hospitalized and matched with 44 controls. One KTR and 4 controls died (case fatality rate: 9.1%). There were no significant differences in length of stay or clinical outcomes between KTR and controls. Tacrolimus or sirolimus levels were >10 ng/mL in 6 out of 9 KTR (67%). Bacterial infections were more frequent in KTR (36.3%), compared with controls (6.8%, P = .02). CONCLUSIONS: In our small case series, unlike earlier reports from the pandemic epicenters, the clinical outcomes of KTR with COVID-19 were comparable to those of non-transplant patients. Calcineurin or mammalian target of rapamycin inhibitor (mTOR) levels were high. Bacterial infections were more common in KTR, compared with controls. |*Kidney Transplantation[MESH] |Adult[MESH] |Aged[MESH] |Antiviral Agents/therapeutic use[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/complications/*diagnosis/virology[MESH] |Case-Control Studies[MESH] |Female[MESH] |Graft Rejection/prevention & control[MESH] |Humans[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |Kidney Failure, Chronic/complications/therapy[MESH] |Length of Stay[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |SARS-CoV-2/isolation & purification[MESH] |Sirolimus/therapeutic use[MESH] |TOR Serine-Threonine Kinases/metabolism[MESH] |Tacrolimus/therapeutic use[MESH]Coronavirus Disease 2019 in Kidney Transplant Recipients: Single-Cente(epmc).pdf DeepDyve Pubget Overpricing